Log in | Register

Search Results

Results 1 to 10 of 95 for "Empirical therapy"

Restrict your results to one of the following articles types (number of results in parentheses):

Restrict your results to those published in the following timeframe (number of results in parentheses):

  1. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock

    J. Garnacho-Montero, A. Gutiérrez-Pizarraya, A. Escoresca-Ortega, Y. Corcia-Palomo, Esperanza Fernández-Delgado, I. Herrera-Melero, C. Ortiz-Leyba, J. A. Márquez-Vácaro
    Volume 40, Number 1 / January, 2014
    Original Article

  2. Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes

    Philipp Schuetz, Beat Mueller
    Volume 40, Number 1 / January, 2014
    Correspondence

  3. Need for a biomarker to de-escalate antimicrobial empirical therapy

    José Garnacho-Montero, Antonio Gutiérrez-Pizarraya, Ana Escoresca-Ortega
    Volume 40, Number 2 / February, 2014
    Correspondence

  4. Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection

    Guido Bertolini, Giovanni Nattino, Carlo Tascini, Daniele Poole, Bruno Viaggi, Greta Carrara, Carlotta Rossi, Daniele Crespi, Matteo Mondini, Martin Langer, Gian Maria Rossolini, Paolo Malacarne
    Volume 44, Number 10 / October, 2018
    Original

  5. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

    Matteo Bassetti, Monia Marchetti, Arunaloke Chakrabarti, Sergio Colizza, Jose Garnacho-Montero, Daniel H. Kett, Patricia Munoz, Francesco Cristini, Anastasia Andoniadou, Pierluigi Viale, Giorgio Della Rocca, Emmanuel Roilides, Gabriele Sganga, Thomas J. Walsh, Carlo Tascini, Mario Tumbarello, Francesco Menichetti, Elda Righi, Christian Eckmann, Claudio Viscoli, Andrew F. Shorr, Olivier Leroy, Geor
    Volume 39, Number 12 / December, 2013
    Original

  6. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

    Matteo Bassetti, Jan J. De Waele, Philippe Eggimann, Josè Garnacho-Montero, Gunnar Kahlmeter, Francesco Menichetti, David P. Nicolau, Jose Arturo Paiva, Mario Tumbarello, Tobias Welte, Mark Wilcox, Jean Ralph Zahar, Garyphallia Poulakou
    Volume 41, Number 5 / May, 2015
    Review

  7. Rationalizing antimicrobial therapy in the ICU: a narrative review

    Jean-François Timsit, Matteo Bassetti, Olaf Cremer, George Daikos, Jan de Waele, Andre Kallil, Eric Kipnis, Marin Kollef, Kevin Laupland, Jose-Artur Paiva, Jesús Rodríguez-Baño, Étienne Ruppé, Jorge Salluh, Fabio Silvio Taccone, Emmanuel Weiss, François Barbier
    Volume 45, Number 2 / February, 2019
    Review

  8. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study

    Liesbet De Bus, Wouter Denys, Julie Catteeuw, Bram Gadeyne, Karel Vermeulen, Jerina Boelens, Geert Claeys, Jan J. De Waele, Johan Decruyenaere, Pieter O. Depuydt
    Volume 42, Number 6 / June, 2016
    Original

  9. Intensive care medicine research agenda on invasive fungal infection in critically ill patients

    Matteo Bassetti, Jose Garnacho-Montero, Thierry Calandra, Bartjan Kullberg, George Dimopoulos, Elie Azoulay, Arunaloke Chakrabarti, Daniel Kett, Cristobal Leon, Luis Ostrosky-Zeichner, Maurizio Sanguinetti, Jean-Francois Timsit, Malcom D. Richardson, Andrew Shorr, Oliver A. Cornely
    Volume 43, Number 9 / September, 2017
    Research Agenda

  10. Impact of de-escalation on ICU patients’ prognosis

    Jan J. De Waele, Matteo Bassetti, Ignacio Martin-Loeches
    Volume 40, Number 10 / October, 2014
    Editorial

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement